Augtyro
NDC 0003-4040, repotrectinib, capsule, from E.R. Squibb & Sons, L.L.C..
- Product NDC
- 0003-4040
- Status
- Listed
- Labeler
- E.R. Squibb & Sons, L.L.C.
- Dosage form
- CAPSULE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA218213
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/0003-4040 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- REPOTRECTINIB40 mg/1
Pharmacologic classes
Cytochrome P450 3A4 Inducers [MoA]; Kinase Inhibitor [EPC]; Proto-Oncogene Tyrosine-Protein Kinase ROS1 Inhibitors [MoA]; Tropomyosin Receptor Tyrosine Kinase A Inhibitors [MoA]; Tropomyosin Receptor Tyrosine Kinase B Inhibitors [MoA]; Tropomyosin Receptor Tyrosine Kinase C Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 0003-4040-12 | 00003404012 | 120 CAPSULE in 1 BOTTLE (0003-4040-12) |
| 0003-4040-60 | 00003404060 | 60 CAPSULE in 1 BOTTLE (0003-4040-60) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/fb526827-40ba-4462-94cf-179ae3b0cb8a
Use it
Look up 0003-4040 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/0003-4040 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 0003-4040. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.